# Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers

> **NCT00222092** · — · COMPLETED · sponsor: **University of Ioannina** · enrollment: 300 (—)

## Conditions studied

- Post-ERCP Acute Pancreatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00222092
- **Lead sponsor:** University of Ioannina
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 300 (—)
- **Last updated:** 2011-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222092, "Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00222092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*